Centiva Capital, LP Innoviva, Inc. Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $16,253 - $19,578	1,427 Added 14.0%	11,619 $147,000
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $109,360 - $138,611	10,192 New	10,192 $114,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $225,221 - $265,000	-14,156 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $184,877 - $244,049	14,156 New	14,156 $236,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.